Dyspnea clinical trials

Explore recruiting dyspnea clinical trials.

Recruiting dyspnea studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dyspnea trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of Inhaled BGF 160 on Complexity and Variability of Tidal Breathing and Oscillatory Mechanics in Stable COPD Patient

France

Therapeutic use (Phase IV) EU CTIS Study details

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Advanced Respiratory Diseases (INFURO)

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

Palliation of Dyspnea and Cough using Morphine in patients with Fibrotic Interstitial Lung Disease

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A randomised, double-blind, comparative clinical trial of the effectiveness and tolerability of fentanyl in continuous parenteral perfusion versus on-demand bolus of morphine for the treatment of refractory dyspnoea in patients hospitalised for acute dec

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

QUIDOSE. Randomized controlled trial testing the efficacy of hydroxychloroquine combined with low dose corticosteroid therapy in pulmonary sarcoidosis.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sustained-release oral morphine to alleviate persistent dyspnea in patients with chronic respiratory insufficiency due to amyotrophic lateral sclerosis outside the administration of ventilatory assistance: prospective multicenter randomized, placebo-controlled study, parallel arms. (OPIDYS-ALS).

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dyspnea trials by city

Dyspnea in Toronto Dyspnea in Vancouver Dyspnea in Montreal Dyspnea in Calgary Dyspnea in Edmonton Dyspnea in Ottawa Dyspnea in Winnipeg Dyspnea in Quebec City Dyspnea in Hamilton Dyspnea in Kitchener Dyspnea in London Dyspnea in Halifax Dyspnea in New York Dyspnea in Los Angeles Dyspnea in Chicago Dyspnea in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease